Acuity Spatial Genomics, Inc
Natalya Kotova is a seasoned professional in the field of molecular biology and research, currently serving as a Senior Research Associate at Acuity Spatial Genomics, Inc since October 2023. With previous experience in similar roles at Switch Therapeutics and Rebus Biosystems, Natalya has significantly contributed to experimental advancements, including refining detection methods for gene targets and optimizing chemistry protocols. Academic training includes a Master’s Degree from the University of Basel and a Bachelor's Degree from the University of California, Merced, alongside extensive research roles at various institutions, focusing on epigenomics, macrophage responses, and cancer metabolism. Technical expertise encompasses a wide array of methodologies such as DNA isolation, PCR, and microscopy techniques.
Acuity Spatial Genomics, Inc
Acuity Spatial Genomics, Inc. provides a ground-breaking platform designed for simultaneous, genome-wide visualization of the 3D genome in single cells and opens new frontiers in spatial multiomic analyses for discovery. Based on patented technologies developed at Harvard University, the company’s OligoFISSEQ and OligoFISSEQ HD technologies empower researchers to visualize the genome organization and 3D chromatin architecture of individual cells, directly in situ, and in an accessible time-to-result and cost-effective approach. The Acuity technology platform enables the possibility to delve deeper and gain critical insight into transcription regulatory programs that drive cell type, state, function, and pathogenesis—and thus advance discovery in areas such as oncology, neuroscience, and disease research. The company has facilities in Massachusetts and California.